Join
Live feed
·
INSIDERFilingvia Quantisnow
Akero Therapeutics Inc. logo

Chief Development Officer Yale Catriona exercised 10,000 shares at a strike of $19.87 and sold $529,467 worth of shares (10,000 units at $52.95) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKRO· Akero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKRO (Akero Therapeutics Inc.) and more on Quantisnow.